Sign In
Buy GMED
$77.95
-0.300 (-0.383%)
At Close: Jun 03, 2026
Globus Medical completes acquisition of Nevro Corp.
08:31am, Thursday, 03'rd Apr 2025
AUDUBON, Pa., April 03, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its previously disclosed acquisitio
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of N
GMED Stock Jumps 41.8% in a Year: What's Behind the Rally?
09:25am, Friday, 21'st Mar 2025
Globus Medical's robust musculoskeletal offerings and synergies from the NuVasive merger are fueling its stock gains.
Should You Hold Globus Medical Stock in Your Portfolio Now?
11:05am, Wednesday, 19'th Mar 2025
GMED stays on investors' radar due to its high NuVasive-merger synergies and solid Musculoskeletal prospects.
New Product Launches Benefit GMED Stock Amid Macro Issues
12:30pm, Tuesday, 18'th Mar 2025
Globus Medical currently awaits a strong cadence of product launches throughout the Musculoskeletal portfolio in the coming months of 2025.
Globus Medical Expands Anterior Spine Portfolio With Two New Offerings
10:12am, Friday, 14'th Mar 2025
GMED announces the commercial launch of COHERE ALIF Spacer and Modulus ALIF Blades.
AUDUBON, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced two commercial launches: COHERE™ ALIF Spacer: The
Globus Medical to feature ExcelsiusFlex™ for Total Knee Arthroplasty at the American Academy of Orthopedic Surgeons Annual Meeting
04:40pm, Thursday, 06'th Mar 2025
AUDUBON, Pa., March 06, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it will participate in the 2025 Annual Meeting of the
Globus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference
07:01pm, Wednesday, 05'th Mar 2025
AUDUBON, Pa., March 05, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it is scheduled to participate in the Canaccord Genuit
Is the Options Market Predicting a Spike in Globus Medical (GMED) Stock?
10:15am, Wednesday, 05'th Mar 2025
Investors need to pay close attention to Globus Medical (GMED) stock based on the movements in the options market lately.
Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results
04:15pm, Tuesday, 04'th Mar 2025
REDWOOD CITY, Calif. , March 4, 2025 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pa
Globus Medical Q4 Earnings & Revenues Top, Margins Expand, Stock Dips
09:20am, Friday, 21'st Feb 2025
GMED's fourth-quarter 2024 performance reflects strong synergies from the NuVasive merger.
Globus Medical, Inc. (GMED) Q4 2024 Earnings Call Transcript
09:54pm, Thursday, 20'th Feb 2025
Globus Medical, Inc. (NYSE:GMED ) Q4 2024 Earnings Conference Call February 20, 2025 4:30 PM ET Company Participants Brian Kearns - SVP, Business Development and IR Daniel Scavilla - President and CEO
Globus Medical (GMED) Reports Q4 Earnings: What Key Metrics Have to Say
08:00pm, Thursday, 20'th Feb 2025
While the top- and bottom-line numbers for Globus Medical (GMED) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics
Globus Medical (GMED) Q4 Earnings and Revenues Top Estimates
06:55pm, Thursday, 20'th Feb 2025
Globus Medical (GMED) came out with quarterly earnings of $0.84 per share, beating the Zacks Consensus Estimate of $0.76 per share. This compares to earnings of $0.60 per share a year ago.
